The Cost of Control: Financial and Administrative Burdens of Limited Distribution Network Changes in Cystic Fibrosis
Pediatric Pulmonology · 2026
DOI: 10.1002/ppul.71829 ↗At a glance
Journal article in Pediatric Pulmonology, 2026. Written by Brittany A Wright and 11 co-authors. Institution: University of California San Diego, La Jolla, California, USA. Major MEDLINE topics: Cystic Fibrosis, Pharmacists, Pharmacy Technicians. 18 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
The clinical impact of pharmacists and pharmacy technicians on the care of people with cystic fibrosis (pwCF) has been well documented within the literature, including medication access, reduction of hospitalizations, and consolidation of pharmaceutical delivery for pwCF with complex medication regimens. However, challenges related to access and affordability have become increasingly complex, increasing the administrative burden placed upon these members of the multidisciplinary CF care team. The goal of this study was to quantify the time pharmacists and pharmacy technicians at CF Foundation‐accredited care centers (CFACC) spent triaging and resolving errors, categorize the types of interventions required, and tabulate the financial burden for pwCF averted through these interventions.
Methods
This study was a retrospective review of pharmacy team members' interactions following a change in limited distribution network of cystic fibrosis transmembrane conductance regulator modulators (CFTRm) over a 4‐month period of time. Each site received institutional review board exemption. Measures were characterized using descriptive statistics and were analyzed in SAS v9.4 (Cary, NC). Collected data were extrapolated to be nationally representative based on the 2023 CFF Patient Registry report.
Results
Six CFACC and 1781 pwCF were included in this review. Of these pwCF, 216 required additional interventions following a required change in the dispensing pharmacy for their CFTRm. Collectively, 201.5 h were spent on resolution of issues during the study period with interventions successfully averting a financial burden to pwCF of $226,094.73. Extrapolations of time and financial burden were estimated to be 3700 h and over $4.2 million, respectively.
Conclusions
Medication access and affordability continue to present significant barriers for pwCF. We aim to highlight the critical services provided by clinical pharmacy teams at CFACC as well as their integrated health‐system specialty pharmacies, and the vital role they play in improving outcomes and providing cost‐effective care for pwCF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- University of California San Diego, La Jolla, California, USA.
- University of Iowa Health Care, Iowa City, Iowa, USA.
- UNC Health, Chapel Hill, North Carolina, USA.
- University of Utah, Salt Lake City, Utah, USA.
- Indiana University Health, Indianapolis, Indiana, USA.
- Riley Hospital for Children at IU Health, Indianapolis, Indiana, USA.
ORCID profiles: Brittany A Wright, Cameron J McKinzie, Charissa W Kam, Casey R Tak, Rebecca S Pettit, Hilary Vogt, David C Young
Cite
APA
Wright, B. A., McKinzie, C. J., Kam, C. W., Tak, C. R., Knockel, L. M., Langhorst, J., Pettit, R. S., Roe, L., Simonson, B., Vogt, H., Willer, N., & Young, D. C. (2026). The Cost of Control: Financial and Administrative Burdens of Limited Distribution Network Changes in Cystic Fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71829
Vancouver
Wright BA, McKinzie CJ, Kam CW, Tak CR, Knockel LM, Langhorst J, et al. The Cost of Control: Financial and Administrative Burdens of Limited Distribution Network Changes in Cystic Fibrosis. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71829
BibTeX
@article{Wright2026,
author = {Wright, Brittany A and McKinzie, Cameron J and Kam, Charissa W and Tak, Casey R and Knockel, Lynnsey M and Langhorst, Julie and Pettit, Rebecca S and Roe, Lynda and Simonson, Billie and Vogt, Hilary and Willer, Nicole and Young, David C},
title = {The Cost of Control: Financial and Administrative Burdens of Limited Distribution Network Changes in Cystic Fibrosis},
journal = {Pediatric Pulmonology},
year = {2026},
doi = {10.1002/ppul.71829}
}
EUVIMED